These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 10851053)

  • 1. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T; Ishihara K; Hibi M
    Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.
    Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T
    EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.
    Sumi T; Fujimoto Y; Nakatsuji N; Suemori H
    Stem Cells; 2004; 22(5):861-72. PubMed ID: 15342949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
    Yamanaka Y; Nakajima K; Fukada T; Hibi M; Hirano T
    EMBO J; 1996 Apr; 15(7):1557-65. PubMed ID: 8612579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells.
    Dahéron L; Opitz SL; Zaehres H; Lensch MW; Andrews PW; Itskovitz-Eldor J; Daley GQ
    Stem Cells; 2004; 22(5):770-8. PubMed ID: 15342941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of myeloid differentiation and survival by Stats.
    Smithgall TE; Briggs SD; Schreiner S; Lerner EC; Cheng H; Wilson MB
    Oncogene; 2000 May; 19(21):2612-8. PubMed ID: 10851060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.
    Liu XH; Kirschenbaum A; Lu M; Yao S; Klausner A; Preston C; Holland JF; Levine AC
    Biochem Biophys Res Commun; 2002 Jan; 290(1):249-55. PubMed ID: 11779161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
    Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
    Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gp130-mediated pathway and left ventricular remodeling.
    Yamauchi-Takihara K
    J Card Fail; 2002 Dec; 8(6 Suppl):S374-8. PubMed ID: 12555148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
    Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
    J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
    Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
    Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Signal of the cytoplasmic regions of leukemia inhibitory factor receptor (LIFR) alpha-subunit and gp130 involves Stat3 activation in leukemic U937 cells].
    Liu H; Tang S; Liu S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):621-3. PubMed ID: 11721361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling.
    Carbia-Nagashima A; Arzt E
    IUBMB Life; 2004 Feb; 56(2):83-8. PubMed ID: 15085931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Jak-STAT pathway stimulated by interleukin 6.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr9. PubMed ID: 15561981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition.
    Fukada T; Ohtani T; Yoshida Y; Shirogane T; Nishida K; Nakajima K; Hibi M; Hirano T
    EMBO J; 1998 Nov; 17(22):6670-7. PubMed ID: 9822610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.